CSIMarket Company Name, Ticker, Customers, else..


Fennec Pharmaceuticals Inc   (NASDAQ: FENCF)
Other Ticker:  
 

Fennec Pharmaceuticals Inc

FENCF's Fundamental analysis



Looking into Fennec Pharmaceuticals Inc growth rates, revenue grew by 7.05 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 2374

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.29 %

Fennec Pharmaceuticals Inc net loss increased from $-2 millions, to $-6 millions in III. Quarter 2024,

• More on FENCF's Growth


Fennec Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Fennec Pharmaceuticals Inc realized cash reduction of $ 1.02 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-0
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.48.


• More on FENCF's Valuation
 
 Total Debt (Millions $) 30
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,165,088
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 3.58
 Tangible Book Value (Per Share $) -0.19

Fennec Pharmaceuticals Inc
realized net loss in trailing twelve months.

Fennec Pharmaceuticals Inc realized cash outflow of $ 1.02per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-0
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.48.


• More on FENCF's Valuation

•  Market Capitalization (Millions $) -
•  Shares Outstanding (Millions) 27
•  Employees 34
•  Revenues (TTM) (Millions $) 40
•  Net Income (TTM) (Millions $) 2
•  Cash Flow (TTM) (Millions $) 28
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) 30
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,165,088
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 3.58
•  Tangible Book Value (Per Share $) -0.19

•  Market Capitalization (Millions $) -
•  Shares Outstanding (Millions) 27
•  Employees 34
•  Revenues (TTM) (Millions $) 40
•  Net Income (TTM) (Millions $) 2
•  Cash Flow (TTM) (Millions $) 28
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 7.8
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.73
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com